>> 全站文章索引 >> 第22页:
  • The Medication Merry-Go-Round - [Kathryn Brown]
  • Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants - [Sammanda Ramamoorthy and Randy D. Blakely]
  • Out in the open - [.]
  • Anxiety disorders and risk for suicide attempts findings from the Baltimore Epidemiologic Catchment area follow-up study - [Bolton JM, Cox BJ, Afifi TO, Enns MW, Bienvenu OJ, Sareen J.]
  • Response in Relation to Baseline Anxiety Levels in Major Depressive Disorder Treated with Bupropion Sustained Release or Sertraline - [A John Rush1 MD, Madhukar H Trivedi1 MD, Thomas J Carmody2 Ph.D, Rafe M J Donahue3 Ph.D, Trisha L Houser3 BA, Carolyn Bolden-Watson3 Ph.D, Sharyn R Batey4 Pharm.D, John A Ascher4 MD and Alan Metz3 MDD:1Department of Psychiatry, University of Texas Southwe]
  • Which factors are important predictors of non-recovery from major depression? A 2-year prospective observational study - [Viinam?ki H, Haatainen K, Honkalampi K, Tanskanen A, Koivumaa-Honkanen H, Antikainen R, Valkonen-Korhonen M, Hintikka J.]
  • Optic Neuritis - [Atkins EJ, Biousse V, Newman NJ.]
  • Opioids in pain management of blood-related malignancies - [Niscola P, Scaramucci L, Romani C, Giovannini M, Maurillo L, del Poeta G, Cartoni C, Arcuri E, Amadori S, De Fabritiis P.]
  • The -Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats - [Mary M Torregrossa1, Ceylan Isgor2, John E Folk3, Kenner C Rice3, Stanley J Watson1,2 and James H Woods1,4]
  • Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases - [Ali Saffet Gonul, Fisun Akdeniz, Ozlem Donat and Simavi Vahip]
  • Effect of Antidepressant Drugs in Mice Lacking the Norepinephrine Transporter - [Marta Dziedzicka-Wasylewska1, Agata Faron-Górecka1, Maciej Kumider1, Elbieta Drozdowska1, Zofia Rogó1, Joanna Siwanowicz1, Marc G Caron2 and Heinz B?nisch3]
  • Perospirone augmentation of paroxetine in treatment of refractory obsessive–compulsive disorder with depression - [Tatsui Otsuka, Takashi Togo, Naoya Sugiyama, Kumi Uehara, Asuka Yoshimi, Aya Karashima, Hiromi Shioya and Yoshio Hirayasu]
  • Diagnosis and treatment of obsessive-compulsive disorder and related disorders - [Dell]
  • Temperature Regulation in Depression: Functional 5HT1A Receptor Adaptation Differentiates Antidepressant Response - [Jeffrey L Rausch1, Maria E Johnson1, Katherine E Kasik1 and Stephen M Stahl2]
  • Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression - [Jantien P. Brouwer, Bente C. Appelhof, Elisabeth F.C. van Rossum, Jan W. Koper, Eric Fliers, Jochanan Huyser, Aart H. Schene, Jan G.P. Tijssen, Richard Van Dyck, Steven W.J. Lamberts, et al.]
  • Open-label trial of paroxetine in children with obsessive-compulsive disorder - [Rasim Somer Diler and Ayse Avci]
  • Reversal of Inappropriate Peripheral Vascular Responses in Hypertrophic Cardiomyopathy - [Rajesh Thaman, Perry M. Elliott, Jaymin S. Shah, Bryan Mist, Lynne Williams, Ross T. Murphy, William J. McKenna and Michael P. Frenneaux]
  • Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation - [Juza Chen, Nicola J. Mabjeesh, Haim Matzkin and Alexander Greenstein]
  • DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats - [Gook Jun Ahn, Kyung Koo Kang, Dong Sung Kim, Byoung Ok Ahn, Won Bae Kim, Sung Keun Kang, Byeong Chun Lee and Woo Suk Hwang]
  • Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: Post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials - [David L. Dunner, Alan Lipschitz, Cornelius D. Pitts and John T. Davies]
  • St John's wort for depression Time for a different perspective - [Pilkington K, Boshnakova A, Richardson J.]
  • Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry review of studies in new drug applications - [Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B.]
  • Is Drug Therapy for Urinary Incontinence Used Optimally in Long-Term Care Facilities - [Narayanan S, Cerulli A, Kahler KH, Ouslander JG.]
  • Randomised controlled trial of problem solving treatment,antidepressant medication - [Mynors-Wallis LM, Gath DH, Day A, Baker F.]
  • Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care - [Oxford University Department of Psychiatry, Warneford Hospital, Oxford OX3 7BJ. lmmw@soton.ac.uk]
  • Religiosity of depressed elderly inpatients - [Payman V, George K, Ryburn B.]
  • Hippocampal atrophy in systemic lupus erythematosus - [Appenzeller S, Carnevalle AD, Li LM, Costallat LT, Cendes F.]
  • Social adjustment based on reported behaviour in bipolar affective disorder - [Morriss R, Scott J, Paykel E, Bentall R, Hayhurst H, Johnson T.]
  • Early identification and high-risk strategies for bipolar disorder - [Correll CU, Penzner JB, Lencz T, Auther A, Smith CW, Malhotra AK, Kane JM, Cornblatt BA.]
  • Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression - [Paola Rocca, Concetta De Leo, Carola Eva, Livio Marchiaro, Anna Maria Milani, Rita Musso, Luigi Ravizza, Enrico Zanalda and Filippo Bogetto]
  • Functional impairment in patients with mania baseline results of the EMBLEM study - [Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E; EMBLEM Advisory Board.]
  • Manic symptoms and impulsivity during bipolar depressive episodes - [Swann AC, Gerard Moeller F, Steinberg JL, Schneider L, Barratt ES, Dougherty DM.]
  • A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia - [Cornelius L. E. Katona, Professor of Psychiatry of the Elderly 1 *, Brian N. Hunter 2, Julia Bray 2 AD:1Department of Psychiatry and Behavioural Sciences,UCL Medical School, London, UK2SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (South)]
  • Comorbid cannabis use and panic disorder: short term and long term follow-up study - [Pinhas N. Dannon 1 2 3 *, Katherine Lowengrub 1 3, Revital Amiaz 2, Leon Grunhaus 2, Moshe Kotler 3 AD:1Rehovot Community Mental Health Care and Rehabilitation Centre, Israel2Chaim Sheba Med Centre, Psychiatry Ward, Tel Hashomer, Israel3Beer Ya]
  • Personality disorders and response to medication treatment in panic disorder: A 1-year naturalistic study - [Carlo Marchesi, Chiara De Panfilis, Alessandro Cantoni, Stefania Fontò, Maria R. Giannelli and Carlo Maggini]
  • Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial - [D.G.S. Perahia, F. Wang, C.H. Mallinckrodt, D.J. Walker and M.J. Detke]
  • social anxiety and insomnia the mediating role of depressive symptoms - [Buckner JD, Bernert RA, Cromer KR, Joiner TE, Schmidt NB.]
  • Anxiety disorders in the 21st century status, challenges, opportunities, and comorbidity with depression - [Devane CL, Chiao E, Franklin M, Kruep EJ.]
  • Effect of treatment of panic disorder in patients with frequent ICD discharges: a pilot study - [P. M. J. C. Kuijpers, A. Honig and H. J. J. Wellens]
  • The effect of 4 weeks treatment with desloratadine (5 mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis - [Tworek D, Bocheńska-Marciniak M, Kupczyk M, Górski P, Kuna P.]
  • Nonepileptic Uses of Antiepileptic Drugs in Children and Adolescents - [Golden AS, Haut SR, Moshé SL.]
  • Effects of Antidepressant Drugs on the Behavioral and Physiological Responses to Lipopolysaccharide (LPS) in Rodents - [Raz Yirmiya1 Ph.D, Yehuda Pollak1 MA, Ohr Barak1 MA, Ronit Avitsur1 Ph.D, Haim Ovadia2 Ph.D, Michael Bette3 Ph.D, Eberhard Weihe3 MD and Joseph Weidenfeld2 Ph.D]
  • Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling - [J. Landgrebe, G. Welzl, T. Metz, M. M. van Gaalen, H. Ropers, W. Wurst and F. Holsboer]
  • Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze - [Dominique Drapier, Danièle Bentué-Ferrer, Bruno Laviolle, Bruno Millet, Hervé Allain, Michel Bourin and Jean-Michel Reymann]
  • Salmon calcitonin potentiates the analgesia induced by antidepressants - [María Jesús Ormazábal, Carlos Goicoechea, Eva Sánchez and María Isabel Martín]
  • A review of the safety of selective serotonin reuptake inhibitors during pregnancy - [David J. Goldstein 1 2 3 *, Karen Sundell 1 AD:1Neuroscience Division, Lilly Research Laboratories, Lilly Corporate Center-1730, Indianapolis, IN 46285, USA2Department of Pharmacology and Toxicology, Indiana University Medical School, Indianapolis, IN, US]
  • Pharmacological Treatment of Adolescent Major Depression - [David Cohen, Priscille Gerardin, Philippe Mazet, Diane Purper-Ouakil, Martine F. Flament]
  • Higher Cortisol Levels Following Exposure to Traumatic Reminders in Abuse-Related PTSD - [Bernet M Elzinga1, Christian G Schmahl2, Eric Vermetten3, Richard van Dyck4 and J Douglas Bremner5,6,7]
  • The four-plates test-retest paradigm to discriminate anxiolytic effects. - [Ripoll N, Nic Dhonnchadha BA, Sebille V, Bourin M, Hascoet M]
  • Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity - [P. Sargent, D. J. Williamson, G. Pearson, J. Odontiadis, P. J. Cowen]
  • Antidepressant medication use and breast cancer risk: a case-control study - [Allan Steingart, Michelle Cotterchio, Nancy Kreiger, Margaret Sloan]
  • Social Impulsivity Inversely Associated with CSF 5-HIAA and Fluoxetine Exposure in Vervet Monkeys - [Lynn A Fairbanks1 Ph.D, William P Melega1,2 Ph.D, Matthew J Jorgensen1 Ph.D, Jay R Kaplan3 Ph.D and Michael T McGuire1,4 MD]
  • Postural hypotension induced by paroxetine - [C Andrews, G Pinner]
  • A direct entry to substituted piperidinones from α,β-unsaturated amides by means of aza double Michael reaction - [Kiyosei Takasu, Naoko Nishida and Masataka Ihara]
  • Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography–mass spectrometry - [Hans J?rg Leis, Werner Windischhofer and Günter Fauler]
  • Determination of paroxetine in geriatric depression by high-performance liquid chromatography - [Isis A. Zainaghi, Vera L. Lanchote and Regina H. C. Queiroz]
  • Selective serotonin reuptake inhibitors in sewage influents and effluents from Troms?, Norway - [Terje Vasskog, Urs Berger, Per-Jostein Samuelsen, Roland Kallenborn and Einar Jensen]
  • Clinical and biological aspects of anti-P-ribosomal protein autoantibodies - [Toubi E, Shoenfeld Y.]
  • Antibody induction of lupus-like neuropsychiatric manifestations - [Lawrence DA, Bolivar VJ, Hudson CA, Mondal TK, Pabello NG]
  • A Mathematical Model for Paroxetine Antidepressant Effect Time Course and Its Interaction with Pindolol - [Berangere Gruwez, Alain Dauphin, Michel Tod]
  • Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers - [Ashwin A. Patkar 1 *, Wade H. Berrettini 2, Allan Lundy 1, Heather W. Murray 1, Kevin P. Hill 1, Michael J. Vergare 1, Stephen P. Weinstein 1 AD:1Division of Substance Abuse Programs, Department of Psychiatry and Human Behavior, Thomas Jefferson Universit]
  • The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test - [Martine Hasco?t, Michel Bourin and Brid A. Nic Dhonnchadha]
  • Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients - [Wendy Chrapko1, Paul Jurasz2,4, Marek W Radomski2,4, Stephen L Archer3, Stephen C Newman1, Glen Baker1, Nathalie Lara1 and Jean-Michel Le Mellédo1]
  • Brain neurosteroid changes after paroxetine administration in mice - [Allon Nechmad, Rachel Maayan, Baruch Spivak, Edward Ramadan, Michael Poyurovsky and Abraham Weizman]
  • Teaching Systems-Based Practice to Primary Care Physicians to Foster Routine Implementation of Evidence-Based Depression Care - [Sherman SE, Fotiades J, Rubenstein LV, Gilman SC, Vivell S, Chaney E, Yano EM, Felker B.]
  • Presence and Characterization of the Serotonin Transporter in Human Resting Lymphocytes - [Donatella Marazziti MD, Alessandra Rossi Dr Biol.Sci, Gino Giannaccini Dr Biol.Sci, Stefano Baroni Dr Biol.Sci, Antonio Lucacchini Dr Biol.Sci and Giovanni B Cassano MD, FRCP]
  • Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies - [Bertrand Aubel, Valérie Kayser, Annie Mauborgne, Antonio Farré, Michel Hamon and Sylvie Bourgoin]
  • Use of antidepressant medications in relation to the incidence of breast cancer - [D Fulton-Kehoe1,2, M A Rossing2,3, C Rutter4, M T Mandelson3,4 and N S Weiss2,3]
  • Delayed pharmacological effects of antidepressants - [A Frazer1,2 and S Benmansour1]
  • A growth in bipolar disorder? - [J.Xu , I.-A. Rasmussen1, E. M. Berntsen1, K. Moss, R. Shnier, J. Lagopoulos, G. S. Malhi]
  • Efficacy of Duloxetine on Cognition, Depression, and Pain in Elderly Patients With Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled Trial - [Joel Raskin, M.D., F.R.C.P.C., Curtis G. Wiltse, Ph.D., Alan Siegal, M.D., M.B.A., Javaid Sheikh, M.]
  • The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis - [Guilherme Polanczyk, M.D., Maur¨ªcio Silva de Lima, M.D., Ph.D., Bernardo Lessa Horta, M.D., Ph.D.,]
  • The FDA Pediatric Advisories and Changes in Diagnosis and Treatment of Pediatric Depression - [Cynthia R. Pfeffer, M.D.]
  • Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy - [Jeffery A Lieberman1, Joel Greenhouse2, Robert M Hamer3, K Ranga Krishnan4, Charles B Nemeroff5, Dav]
  • Music therapy for schizophrenia or schizophrenia-like illnesses - [C Gold, TO Heldal, T Dahle, T Wigram]
  • Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients - [Mark Zetin,MD, Cara T. Hoepner, RN, and Lynda Bjornson, PhD]
  • Interpersonal problems and emotional intelligence in compulsive hoarding - [Jessica R. Grisham, Ph.D., Gail Steketee, Ph.D., Randy O. Frost, Ph.D.]
  • Twelve-Month Outcome of Adolescents With Bipolar Disorder Following First Hospitalization for a Manic or Mixed Episode - [Melissa P. DelBello, M.D., M.S., Dennis Hanseman, Ph.D., Caleb M. Adler, M.D., David E. Fleck, Ph.D.]
  • What Have We Learned About the Neurobiology of Major Depression? - [Maria A. Oquendo, M.D. and Ramin V. Parsey, M.D.]
  • Social anxiety and insomnia: the mediating role of depressive symptoms - [Julia D. Buckner, Rebecca A. Bernert,Kiara R. Cromer, Thomas E. Joiner,Norman B. Schmidt]
  • Maternal anxiety- course and antecedents during the early postpartum period - [John R. Britton, M.D, Ph.D]
  • New generation antipsychotics for first episode schizophrenia - [C Rummel, J Hamann, W Kissling, S Leucht]
  • Early identification and high-risk strategies for bipolar disorder - [Christoph U Corrella,b, Julie B Penznerc, et al]
  • Generalized anxiety disorder: a 40-year follow-up study - [G. Rubio, J. J. L¨®pez-Ibor]
  • SSRIs antidepressant activity is influenced by Gβ3 variants - [Alessandro Serretti, Cristina Lorenzi, Cristina Cusin, Raffaella Zanardi, Enrico Lattuada, David Rossini, Roberta Lilli, Adele Pirovano, Marco Catalano and Enrico Smeraldi]
  • Pharmacokinetics of selective serotonin reuptake inhibitors - [Christoph Hiemke and Sebastian H?rtter]
  • Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection - [Chien-Tsai Lai, Emily S. Gordon, Sidney H. Kennedy, Alan N. Bateson, Ronald T. Coutts and Glen B. Baker]
  • Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment - [David Michelson, Jay Amsterdam, Jeffrey Apter, Maurizio Fava, Peter Londborg, Roy Tamura and Lisa Pagh]
  • Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice - [Martine Hasco?t, Michel Bourin, Marie Claude Colombel, Alexandra J. Fiocco and Glen B. Baker]
  • A novel serotonin transporter ligand: (5-Iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol - [Zhi-Ping Zhuang, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton and Hank F. Kung]
  • Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood - [Gunther H. Moll, Claas Mehnert, Maike Wicker, Nathalie Bock, Aribert Rothenberger, Eckart Rüther and Gerald Huether]
  • Effects of repeated phencyclidine treatment on serotonin transporter in rat brain - [Takafumi Hori, Shuzo Abe, Atsuomi Baba, Toshihito Suzuki and Hiroyasu Shiraishi]
  • Aging regulates 5-HT1B receptors and serotonin reuptake sites in the SCN - [Marilyn J. Duncan, Charles J. Crafton and Deborah L. Wheeler]
  • The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro - [C. M. Helgason, J. L. Wieseler Frank, D. R. Johnson, M. G. Frank and S. E. Hendricks]
  • Gas chromatographic–mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi deriva - [Hans H. Maurer, Joerg Bickeboeller-Friedrich and Thomas Kraemer]
  • Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat - [Yves Charnay, Isabelle Cusin, Philippe G. Vallet, Patrick Muzzin, Fran?oise Rohner-Jeanrenaud and Constantin Bouras]
  • Paroxetine binding in aggressive schizophrenic patients - [Ilan Modai, Anatoly Gibel, Boris Rauchverger, Michael Ritsner, Ehud Klein and Dorit Ben-Shachar]
  • Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers - [R. Schl?sser, H. Wetzel, H. D?rr, W. Rossbach, Ch. Hiemke and O. Benkert]
  • Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain - [C. Vilpoux, I. Leroux-Nicollet, L. Naudon, R. Raisman-Vozari and J. Costentin]
  • Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain - [Agnès Besson, Nasser Haddjeri, Pierre Blier and Claude de Montigny]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 [22] 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50